Dr. Reddy's Laboratories Limited or Geron Corporation: Who Invests More in Innovation?

Comparing R&D Investments: Dr. Reddy's vs. Geron

__timestampDr. Reddy's Laboratories LimitedGeron Corporation
Wednesday, January 1, 20141240200000020707000
Thursday, January 1, 20151744900000017831000
Friday, January 1, 20161783400000018047000
Sunday, January 1, 20171955100000011033000
Monday, January 1, 20181826500000013432000
Tuesday, January 1, 20191560700000052072000
Wednesday, January 1, 20201541000000051488000
Friday, January 1, 20211654100000085727000
Saturday, January 1, 20221748200000095518000
Sunday, January 1, 202319381000000125046000
Monday, January 1, 202422873000000
Loading chart...

Unleashing the power of data

Innovation Investment: A Tale of Two Companies

In the competitive world of pharmaceuticals, innovation is key. Dr. Reddy's Laboratories Limited and Geron Corporation are two companies that have consistently invested in research and development (R&D) to stay ahead. From 2014 to 2023, Dr. Reddy's Laboratories has shown a robust commitment to innovation, with R&D expenses growing by approximately 84%, peaking in 2023. In contrast, Geron Corporation, while significantly smaller in scale, has also increased its R&D spending by nearly 500% over the same period, reflecting its strategic focus on innovation. However, data for 2024 is missing for Geron, indicating potential reporting delays or strategic shifts. This comparison highlights the varying scales and strategies of investment in innovation between a large pharmaceutical giant and a smaller biotech firm. As the industry evolves, these investments will likely play a crucial role in shaping the future of healthcare.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025